A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse

Betti Giusti1, Gabriella Fibbi, Francesca Margheri

  • 1Department of Medical and Surgical Critical Care - DENOTHE, University of Florence, Florence, Italy. b.giusti@DAC.UNIFI.IT

Insights

Systemic sclerosis (SSc) impairs angiogenesis by altering endothelial cell gene expression. SSc cells show complex changes, including up-regulation of pro-angiogenic and inhibitory genes, leading to defective blood vessel formation.

Area of Science:

  • Molecular Biology
  • Vascular Biology
  • Human Genetics

Background:

  • Systemic sclerosis (SSc) is a human disease characterized by insufficient angiogenesis.
  • Microvascular endothelial cells play a critical role in angiogenesis.

Purpose of the Study:

  • To identify genes involved in impaired angiogenesis in SSc.
  • To compare transcriptomes of endothelial cells from normal subjects and SSc patients.

Main Methods:

  • Gene expression profiling using oligonucleotide microarrays (14,000 transcripts).
  • Analysis of differential gene expression and functional categorization using Gene Ontology.
  • Validation of key gene expression changes using quantitative PCR, Western blotting, in vitro angiogenesis assays, and immunohistochemistry.

Main Results:

  • Approximately 3% of analyzed transcripts (199) were differentially expressed in SSc endothelial cells.
  • SSc cells showed overexpression of pro-angiogenic transcripts alongside upregulation of negative regulators and downregulation of cell migration/cytoskeleton genes.
  • Upregulation of transcripts related to protein degradation and ubiquitination was observed in SSc cells.

Conclusions:

  • Microvascular endothelial cells in SSc patients exhibit widespread gene expression abnormalities.
  • These genetic alterations collectively contribute to the defective angiogenesis observed in systemic sclerosis.

Related Concept Videos